Skip to main content
. 2016 Feb 23;7(15):19824–19839. doi: 10.18632/oncotarget.7627

Figure 2. Real-time quantitative PCR analysis of 14 differential circulating miRNAs.

Figure 2

A. Relative expression levels of the 14 circulating miRNAs between HCC recipients at early-phase after liver transplantation (LT-2hr) and healthy donors. B. Expression profiles of the 14 early-phase circulating miRNAs between recipients with and without HCC recurrence after liver transplantation (LT-2hr). *, p<0.05; **, p<0.01; ***, p<0.001.